EMMAC Life Sciences raises £15 million via an Issue of Convertible Notes

EMMAC Life Sciences Group, Europe’s leading independent Cannabis company, has announced that it has successfully raised £15 million. The sum was raised via an issue of Convertible Notes (the ‘CLN issue’). The CLN Issue saw funds coming from a range of new and existing private and institutional investors based in Europe, North America, Asia, and… The post EMMAC Life Sciences raises £15 million via an Issue of Convertible Notes appeared first on Canex.

Excerpt only …
READ MORE BELOW
Source : CANEX CORPORATE
Link to original : EMMAC Life Sciences raises £15 million via an Issue of Convertible Notes
reposted by Cannabis News World